OBSV ObsEva SA

8.45
-0.35  -4%
Previous Close 8.80
Open 8.98
Price To book 5.66
Market Cap 250.38M
Shares 29,631,000
Volume 8,736
Short Ratio 0.33
Av. Daily Volume 17,876

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 trial to be initiated 2H 2017.
OBE022
Pre-term labor
Phase 2 trial did not meet primary endpoint in 2016. Phase 3 European trial initiation announced March 7, 2017. Data due 1H 2018.
OBE001 - IMPLANT2
IVF
Phase 3 trial to be initiated 1H 2017 with data due 1H 2020.
OBE2109 - PRIMROSE
Uterine fibroids
Phase 2b data due 1H 2018.
OBE2109 - EDELWEISS
Endometriosis